Recent Updates
Recently added Catalysts

National Vision Holdings, Inc.

EYEFDA catalysts, PDUFA dates & pipeline intelligence
$17.85
▼ -0.09 · -0.5%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full EYE financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $14.7552W HIGH $30.02
Volume
2.53 M
Value Traded
45.57 M
Short % Float
20.5%
Days to Cover
9.7
+7.27%Week
+6.63%1 Month
-20.56%3 Month
-21.81%6 Month

Cash Data

Unlock EYE cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
1.41 B
EPS (TTM)
0.64
P/E Ratio
28.07
Ent. Value
1.62 B
Total Shares
79.07 M
Float Shares
76.77 M
Insiders
2.91%
Institutions
130.67%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every EYE catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

EYE Catalyst Timeline

Dated clinical, regulatory and corporate events for National Vision Holdings, Inc.

Catalyst Timeline

Dated clinical, regulatory & corporate events for National Vision Holdings, Inc.

3Total events
1Upcoming
0Tier-1 (high impact)
2026 to 2027Coverage

Upcoming catalysts 1

T2Timing Guidance
Subscribe to view catalyst details

Event history 2

●Quarterly UpdateCorporate
Q2 2026 financial results to be reported
●Timing GuidancePresentation
Conference call to discuss Q2 2026 results and fiscal 2026 guidance
Unlock the full EYE catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How EYE actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all EYE historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

National Vision Holdings, Inc. is a medical device company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every EYE program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Scroll for more · summaries link to the source press release
Unlock every EYE trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock EYE insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Cutler David GOfficer (Chief Technology Officer)Option 12,998 12,998 held$0.00 09/08/2026
Unlock the full EYE insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
No hedge fund reported a 13F position in EYE for Q2 2026.
Unlock every fund holding EYE
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in EYE
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see EYE ownership
Insider and institutional ownership, quarter by quarter.

EYE Short Interest

Shares sold short, counted twice a month.

20.5%
Short % of Float
of tradable shares sold short
15.7M
Shares Sold Short
+1.3% vs prior count
9.7 High
Days to Cover
trading days of normal volume to buy every short share back
1.6M
Avg Daily Volume
the average used for days to cover
Unlock EYE short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2026-11-20
Unlock EYE option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live EYE option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock EYE options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How EYE ranks across every disease it competes in

Competitive Position is a premium feature
See how EYE ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

EYE News

-EYE
Nov 5, 2026
EYEGeneral
▼ -0.5%today

America's Best Opens Flagship Store Built Around One Connected Experience

National Vision Holdings (NASDAQ: EYE) opened a flagship America's Best store in Alpharetta, Georgia, on November 5, 2026. The location merges clinical care, eyewear, and technology into one connected journey. The design replaces traditional check-ins with open spaces for personalized guidance. This approach aims to redefine the optical retail experience for customers.

Read more →
-EYE
Oct 29, 2026
EYEConferences/Events
▲ +7.6%on this news

National Vision Holdings, Inc. Announces Third Quarter 2026 Earnings Release and Conference Call

National Vision Holdings, Inc. will announce its third quarter 2026 financial results on November 12, 2026, before market opening. The company will host a conference call at 8:30 a.m. Eastern Time, with pre-registration available on its website. A live audio webcast will be accessible, along with a replay after the event.

Read more →
-EYE
Oct 12, 2026
EYEGeneral

National Vision Launches 2026-2027 Scholarship Program, Exploring the Balance Between Innovation and Human Connection

National Vision Holdings, Inc. has launched its annual scholarship program for optometry students, offering up to $7,500. This year's theme focuses on the balance between innovation and human connection. The program invites third- and fourth-year students to submit essays or video presentations on this topic.

Read more →
-EYE
Oct 1, 2026
EYEConferences/Events

Rise Nano Optics to Attend the 2026 Cantech Investment Conference in Toronto

Rise Nano Optics Ltd. will participate in the 2026 Cantech Investment Conference on October 8, 2026, in Toronto. The event is a key platform for emerging technology companies to connect with investors. Rise aims to showcase its patented SPECTRAGUARD™ technology and discuss its commercialization strategy. The conference is sold out, reflecting significant interest in the event.

Read more →
-EYE
Sep 24, 2026
EYEConferences/Events

Rise Nano Optics to Sponsor INVISION MATCH! 2026, Connecting SpectraGuard with Leading Independent Eye Care Practices

Rise Nano Optics Ltd. will sponsor INVISION MATCH! 2026, an exclusive event connecting independent optometry practice owners with optical suppliers. Scheduled for September 30 to October 2, 2026, in Las Vegas, the event will facilitate one-on-one meetings to promote Rise's SpectraGuard technology. This initiative is part of Rise's strategy to enhance visibility and demand in the U.S. eye care market.

Read more →
-EYE
Sep 16, 2026
EYEConferences/Events

Rise Nano Optics to Attend the Vision Council's 2026 Lab Leadership Forum

Rise Nano Optics Ltd. will participate in The Vision Council's 2026 Lab Leadership Forum, focusing on its SpectraGuard™ lens technology. The event, held in Henderson, Nevada, aims to foster collaboration among optical laboratory leaders. Erik Ritchie, the Chief Commercial Officer, will represent the company as it seeks to expand its market presence and partnerships.

Read more →
-EYE
Sep 8, 2026
EYEGeneral

EYEGLASS WORLD REFRESHES ITS BRAND WITH VML: DEBUTING "CHANGE YOUR GLASSES. CHANGE YOUR WORLD."

National Vision Holdings launched a brand refresh for Eyeglass World with the campaign "Change Your Glasses. Change Your World." The company partnered with creative agency VML to update its identity and reach style-conscious consumers. This initiative aims to position the optical retailer as a digital destination for curated eyewear. The move supports the company's goal of enhancing customer experience across its network.

Read more →
-EYE
Aug 26, 2026
EYEConferences/Events

National Vision, Inc. Announces Participation in Barclays 19th Annual Global Consumer Conference

National Vision Holdings, Inc. has announced its participation in the Barclays 19th Annual Global Consumer Conference, scheduled for September 9, 2026. The presentation will take place at 12:45 p.m. Eastern Time. Investors can access a live webcast of the event on the company's website, which will also be archived for later viewing.

Read more →
-EYE
Aug 12, 2026
EYEGeneral
▼ -11.6%on this news

National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results

National Vision Holdings, Inc. has announced its financial results for the second quarter of 2026. As one of the leading optical retailers in the United States, the report highlights the company's performance during this period. Further details on revenue and growth metrics were not provided in the brief announcement.

Read more →
-EYE
Jul 29, 2026
EYEConferences/Events

National Vision Holdings, Inc. Announces Second Quarter 2026 Earnings Release and Conference Call

National Vision Holdings, Inc. will release its second quarter 2026 financial results on August 12, 2026, before the market opens. A conference call will follow at 8:30 a.m. Eastern Time, allowing investors to engage directly with the company's leadership. Pre-registration for the call is available on the company's website.

Read more →
-EYE
May 20, 2026
EYEConferences/Events

National Vision, Inc. Announces Participation in William Blair 46th Annual Growth Stock Conference

National Vision, Inc. will participate in the William Blair 46th Annual Growth Stock Conference. This event is an opportunity for the company to engage with investors and discuss its growth strategies. Further details about the conference or the company's presentation have not been disclosed.

Read more →
-EYE
May 13, 2026
EYEGeneral
▼ -19.2%on this news

National Vision Holdings, Inc. Reports First Quarter 2026 Financial Results

National Vision Holdings, Inc. reported a strong financial performance for Q1 2026, with a 6.6% increase in net revenue and a significant rise in net income to $31.2 million. The company is focusing on strategic initiatives to enhance store experiences and expand its managed care business. Additionally, it has strengthened its military retail presence by adding new stores. The outlook for fiscal 2026 remains optimistic, with expected revenue growth and store openings.

Read more →
-EYE
Apr 29, 2026
EYEConferences/Events
▼ -7%on this news

National Vision Holdings, Inc. Announces First Quarter 2026 Earnings Release and Conference Call

National Vision Holdings, Inc. will release its first quarter 2026 earnings on May 13, 2026, before market opening. A conference call will be held at 8:30 a.m. Eastern Time for investors to discuss the results. The company operates over 1,200 stores across the U.S. and focuses on making eye care affordable.

Read more →
-EYE
Mar 10, 2026
EYEGeneral

National Vision Announces Winners of 11th Annual Scholarship Program

National Vision Holdings announced the winners of its 11th annual scholarship program, awarding $12,500 to three optometry students. The program encourages students to explore the impact of emerging technology on eye care accessibility. Winners include Isabelle Kreydin, Eliana Goncuian, and Alexa Frye, who presented insightful analyses on this critical topic.

Read more →
-EYE
Mar 4, 2026
EYEGeneral
▲ +9%on this news

National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2025 Financial Results

National Vision Holdings, Inc. reported strong financial results for Q4 and fiscal 2025, with net revenue rising 15.1% to $503.4 million. The company achieved 12 consecutive quarters of positive comparable store sales growth. Adjusted Operating Income increased significantly, reflecting effective cost management and strategic transformation efforts. The outlook for fiscal 2026 remains optimistic with projected revenue growth.

Read more →
-EYE
Nov 5, 2025
EYEGeneral

National Vision Holdings, Inc. Reports Third Quarter 2025 Financial Results Transformation Initiatives Continue to Drive Strong Performance

National Vision Holdings, Inc. has reported a strong performance for the third quarter of 2025, showing a 7.9% increase in net revenue compared to the previous year. The company has achieved continued growth in comparable store sales for the 11th consecutive quarter, leading to an improved fiscal outlook. Adjusted Operating Income increased significantly, reflecting the effectiveness of the company's strategic initiatives. However, customer traffic has remained flat, posing a challenge for future sales growth.

Read more →
-EYE
Aug 6, 2025
EYEGeneral

National Vision Holdings, Inc. Reports Second Quarter 2025 Financial Results Accelerated Initiatives Drive Comparable Store Sales Growth and Improved Profitability

National Vision Holdings, Inc. has reported its financial results for the second quarter of 2025, highlighting a net revenue increase of 7.7% compared to the same period in 2024. Improved profitability is evident with a 69.1% rise in Adjusted Operating Income. The company has raised its fiscal 2025 outlook, projecting stronger revenues and operating income. Furthermore, the firm has experienced ten consecutive quarters of positive comparable store sales growth, reflecting successful operational strategies and customer engagement.

Read more →
-EYE
May 7, 2025
EYEGeneral
▲ +17.1%on this news· ran to +41% by day 3

National Vision Holdings, Inc. Reports First Quarter 2025 Financial Results Successful Execution of New Transformation Initiatives and Cost Reduction Actions Delivered Strong First Quarter

National Vision Holdings, Inc. reported its financial results for the first quarter of 2025, showing a 5.7% increase in net revenue to $510.3 million compared to the previous year. The company's comparable store sales have shown consistent growth, marking the ninth consecutive quarter of positive performance. Adjusted operating income saw a significant rise by 21.8%, reflecting operational improvements. Looking ahead, the company has raised its fiscal 2025 outlook, signaling strong confidence in its strategic initiatives despite some negative impacts from unearned revenue and rising costs.

Read more →
-EYE
Apr 29, 2025
EYEGeneral

National Vision Appoints Alex Wilkes as CEO Reade Fahs to Assume Executive Chairman Position

National Vision Holdings, Inc. has appointed Alex Wilkes as the new Chief Executive Officer, effective August 1, 2025. He will succeed Reade Fahs, who will transition to the role of Executive Chairman. This leadership change is seen as a part of the company's transformation strategy, aiming for continued growth and success in the optical retail sector. Mr. Wilkes, who joined National Vision in August 2024, has a strong background in the industry and aims to leverage his experience for the company's future.

Read more →
-EYE
Mar 17, 2025
EYEGeneral

National Vision Appoints Jim McGrann and Michael Nicholson to Board of Directors

National Vision Holdings, Inc. has announced the appointment of Jim McGrann and Michael Nicholson as new independent directors to its Board, expanding the Board from 9 to 11 members. This move is part of a Cooperation Agreement with Engine Capital to enhance the company's strategic initiatives. McGrann and Nicholson bring extensive experience in the optical and retail industries, respectively, which is expected to contribute significantly to National Vision's ongoing transformation efforts. The company aims to capitalize on growth opportunities while delivering value to its shareholders.

Read more →

About National Vision Holdings, Inc.

Alpharetta, GA 13,138 employees nationalvision.com
Headquarters6000 AVALON BOULEVARD, ALPHARETTA, GA, 30009
BIOPHARMAWATCH ELITE PLUS
Trade the next EYE catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime